flow cytometry
flow cytometry is an intervention with 167 clinical trials. Currently 5 active trials ongoing. Historical success rate of 83.5%.
Success Metrics
Based on 111 completed trials
Phase Distribution
Phase Distribution
51
Early Stage
31
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
78.2%
111 of 142 finished
21.8%
31 ended early
5
trials recruiting
167
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Exploring Novel Diagnostic Tools for Periprosthetic Joint Infection
Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom Allergy
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Clinical Trials (167)
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Exploring Novel Diagnostic Tools for Periprosthetic Joint Infection
Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom Allergy
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma
AYLo - AutoimmunitY and Loss of y
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Evaluation of ClearLLab LS Screening Panel
Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas
Role of Follicular T Cells in Hashimoto's Thyroiditis
Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
T Lymphocyte Subsets in Ulcerative Colitis
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
The Role of NK Cells to Detect Blood Infection in ALL.
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 167